{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T15:19:04Z","timestamp":1758122344463},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1993,3,1]],"date-time":"1993-03-01T00:00:00Z","timestamp":730944000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[1993,3]]},"DOI":"10.1007\/bf03344940","type":"journal-article","created":{"date-parts":[[2014,3,18]],"date-time":"2014-03-18T10:09:30Z","timestamp":1395137370000},"page":"175-179","source":"Crossref","is-referenced-by-count":8,"title":["Relationship between serum CA 125 levels, endometrial thickness and corpus luteum function in different stages of ovarian activity"],"prefix":"10.1007","volume":"16","author":[{"given":"G.","family":"\u00d6zak\u015fit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. \u00d6.","family":"Turhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Oral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Do\u011fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"G\u00f6kmen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,18]]},"reference":[{"key":"BF03344940_CR1","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJM198310133091503","volume":"309","author":"RC Bast Jr.","year":"1983","unstructured":"Bast R.C.Jr., Klug T.L., St.John E. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N. Engl. J. Med. 309: 883, 1983.","journal-title":"N. Engl. J. Med."},{"key":"BF03344940_CR2","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/bjc.1984.254","volume":"50","author":"PA Channey","year":"1984","unstructured":"Channey P.A., Moore M., Wilkonson P.M., James R.D. Ovarian cancer antigen CA 125: a prospective clinical assessment of its role as a tumor marker. Br. J. Cancer 50: 765, 1984.","journal-title":"Br. J. Cancer"},{"key":"BF03344940_CR3","first-page":"703","volume":"64","author":"JM Niloff","year":"1984","unstructured":"Niloff J.M., Knapp R.C., Schaetzl E., Reynolds C., Bast R.C.Jr. CA 125 antigen levels in obstetric and gynecologic patients. Obstet. Gynecol. 64: 703, 1984.","journal-title":"Obstet. Gynecol."},{"key":"BF03344940_CR4","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0015-0282(16)60430-2","volume":"51","author":"DE Pittaway","year":"1989","unstructured":"Pittaway D.E., Douglas J.W. Serum CA-125 in women with endometriosis and chronic pelvic pain. Fertil. Steril. 51: 68, 1989.","journal-title":"Fertil. Steril."},{"key":"BF03344940_CR5","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0015-0282(16)49333-7","volume":"45","author":"RL Barbieri","year":"1986","unstructured":"Barbieri R.L, Niloff J.M., Bast R.C.Jr., Schaetzl E., Kistner R.W., Knapp R.C. Elevated serum concentrations of CA-125 in patients with advanced endometriosis. Fertil. Steril. 45: 630, 1986.","journal-title":"Fertil. Steril."},{"key":"BF03344940_CR6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0002-9378(87)90207-9","volume":"156","author":"DE Pittaway","year":"1987","unstructured":"Pittaway D.E., Fayez J.A. Serum CA-125 antigen levels increase during menses. Am. J. Obstet. Gynecol. 156: 75, 1987.","journal-title":"Am. J. Obstet. Gynecol."},{"key":"BF03344940_CR7","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0015-0282(16)59484-9","volume":"48","author":"W J\u00e4ger","year":"1987","unstructured":"J\u00e4ger W., Diedrich K., Wildt L. Elevated levels of CA-125 in serum of patients suffering from ovarian hyperstimulation syndrome. Fertil. Steril. 48: 675, 1987.","journal-title":"Fertil. Steril."},{"key":"BF03344940_CR8","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0015-0282(16)53753-4","volume":"54","author":"A Zweers","year":"1990","unstructured":"Zweers A., De Boever J., Serreyn R., Vandekerckhove D. Correlation between peripheral CA-125 levels and ovarian activity. Fertil. Steril. 54: 409, 1990.","journal-title":"Fertil. Steril."},{"key":"BF03344940_CR9","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0015-0282(16)53754-6","volume":"54","author":"A Lanzone","year":"1990","unstructured":"Lanzone A., Fulghesu A.M., Guida C., Muscatello R., Caruso A., Mancuso S. Serum CA-125 levels do not depend on ovarian steroidogenesis. Fertil. Steril. 54: 415, 1990.","journal-title":"Fertil. Steril."},{"key":"BF03344940_CR10","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/0028-2243(85)90130-3","volume":"19","author":"RC Bast","year":"1985","unstructured":"Bast R.C., Knapp R.C. Use of the CA 125 antigen in diagnosis and monitoring of ovarian carcinoma. Eur. J. Obstet. Gynecol. Biol. 19: 354, 1985.","journal-title":"Eur. J. Obstet. Gynecol. Biol."},{"key":"BF03344940_CR11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF00389242","volume":"111","author":"M Dietel","year":"1986","unstructured":"Dietel M., Arps H., Klapdor R., M\u00fcller-Hagen S., Sieck M., Hoffmann L. Antigen detection by the monoclonal antibodies CA 19-9 and CA 125 in normal and tumor tissue and patients sera. J. Cancer Res. Clin. Oncol. 111: 257, 1986.","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"BF03344940_CR12","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/0002-9378(86)90757-X","volume":"154","author":"HWA Bruijn de","year":"1986","unstructured":"de Bruijn H.W.A., van Beeck Calkoen-Corpay T., Jager S., Duk J.M., Aalders J.G., Fleuren G.J. The tumor marker CA 125 is a common constituent of normal cervical mucus. Am. J. Obstet. Gynecol. 154: 1088, 1986.","journal-title":"Am. J. Obstet. Gynecol."},{"key":"BF03344940_CR13","first-page":"19","volume":"79","author":"L Fedele","year":"1988","unstructured":"Fedele L., Arcaini L., Vercellini P., Bianchi S., Condiani G. Serum CA-125 measurement in the diagnosis of endometriosis recurrence. Obstet. Gynecol. 79: 19, 1988.","journal-title":"Obstet. Gynecol."},{"key":"BF03344940_CR14","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/1097-0142(19871115)60:10<2437::AID-CNCR2820601015>3.0.CO;2-K","volume":"60","author":"GJ Fleuren","year":"1987","unstructured":"Fleuren G.J., Nap M., Aalders J.G., Trimbos J.B., De Bruijn H.W.A. Explanation of the limited correlation between tumor CA 125 content and serum CA 125 antigen levels in patients with ovarian tumors. Cancer 60: 2437, 1987.","journal-title":"Cancer"},{"key":"BF03344940_CR15","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/1097-0142(19860401)57:7<1327::AID-CNCR2820570713>3.0.CO;2-Z","volume":"57","author":"H Halila","year":"1986","unstructured":"Halila H., Stenman U.H., Sepp\u00e4l\u00e4 M. Ovarian cancer antigen CA 125 levels in pelvic inflammatory disease and pregnancy. Cancer 57: 1327, 1986.","journal-title":"Cancer"},{"key":"BF03344940_CR16","first-page":"2139","volume":"10","author":"N Inaba","year":"1985","unstructured":"Inaba N., Fukazawa I., Ota Y., Nito A., Ijichi M., Sato T., Takamizawa H. Tissue polypeptide antigen and cancer antigen 125 in pregnancy-these two cancer-related antigens are oncoplacental? Acta Obstet. Gynecol. Jpn. 10: 2139, 1985.","journal-title":"Acta Obstet. Gynecol. Jpn."},{"key":"BF03344940_CR17","first-page":"2091","volume":"49","author":"A Berchuck","year":"1989","unstructured":"Berchuck A., Soisson A.P., Clarke-Peorson D.L., Soper J.T., Boyer C.M. Immunohistochemical expression of CA 125 in endometrial adenocarcinoma: correlation of antigen expression with metastatic potential. Cancer Res. 49: 2091, 1989.","journal-title":"Cancer Res."},{"key":"BF03344940_CR18","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/oxfordjournals.humrep.a136445","volume":"1","author":"P Bischof","year":"1986","unstructured":"Bischof P., Tseng L., Brioschi P.A., Herrmann W.L. Cancer antigen 125 is produced by human endometrial cells. Hum. Reprod. 1: 423, 1986.","journal-title":"Hum. Reprod."},{"key":"BF03344940_CR19","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1095\/biolreprod42.4.721","volume":"42","author":"J Weintraub","year":"1990","unstructured":"Weintraub J., Bischof P., Tseng L., Redard M., Vassilakos P. CA 125 is an excretory product of human endometrial glands. Biol. Reprod. 42: 721, 1990.","journal-title":"Biol. Reprod."},{"key":"BF03344940_CR20","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1471-0528.1990.tb02449.x","volume":"97","author":"P Lehtovirta","year":"1990","unstructured":"Lehtovirta P., Apter D., Stenman U.H. Serum CA 125 levels during menstrual cycle. Br. J. Obstet. Gynecol. 97: 930, 1990.","journal-title":"Br. J. Obstet. Gynecol."},{"key":"BF03344940_CR21","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1111\/j.1471-0528.1988.tb06798.x","volume":"95","author":"IJ Jacobs","year":"1988","unstructured":"Jacobs I.J., Fay T.N., Stabile I., Bridges J.E., Oram D.M., Grudzinskas J.G. The distribution of CA 125 in the reproductive tract of pregnant and nonpregnant women. Br. J. Obstet. Gynecol. 95: 1190, 1988.","journal-title":"Br. J. Obstet. Gynecol."},{"key":"BF03344940_CR22","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1093\/clinchem\/32.11.2110","volume":"32","author":"W Mastropaola","year":"1986","unstructured":"Mastropaola W., Fernandez Z., Miller E.L. Pronounced increases in the correlation of an ovarian tumour marker CA 125, in serum of a healthy subject during menstruation. Clin. Chem. 32: 2110, 1986.","journal-title":"Clin. Chem."},{"key":"BF03344940_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/humrep\/4.suppl_1.1","volume":"4","author":"I Jacobs","year":"1989","unstructured":"Jacobs I., Bast R.C. The CA 125 tumour-associated antigen: a review of the literature. Hum. Reprod. 4: 1, 1989.","journal-title":"Hum. Reprod."},{"key":"BF03344940_CR24","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00004347-198303000-00005","volume":"2","author":"SE Kabawat","year":"1983","unstructured":"Kabawat S.E., Bast R.C., Bhan A.K., Welch W.R., Knapp R.C., Colvin R.B. Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC 125. Int. J. Gynecol. Pathol. 2: 275, 1983.","journal-title":"Int. J. Gynecol. Pathol."}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03344940.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03344940\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03344940","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,16]],"date-time":"2020-08-16T11:40:01Z","timestamp":1597578001000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03344940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,3]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1993,3]]}},"alternative-id":["BF03344940"],"URL":"https:\/\/doi.org\/10.1007\/bf03344940","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,3]]}}}